APA (7th ed.) Citation

X, Y., L, W., H, W., X, L., Z, W., S, Y., & J, Y. (2026). Baseline [18F]FDG PET/CT characterization of extramedullary disease and prognostic value in relapsed/refractory B-cell acute lymphoblastic leukemia treated with CAR-T cells. European journal of nuclear medicine and molecular imaging, 53(3), 1691. https://doi.org/10.1007/s00259-025-07562-y

Chicago Style (17th ed.) Citation

X, Yao, Wei L, Wang H, Lei X, Wang Z, Yao S, and Yang J. "Baseline [18F]FDG PET/CT Characterization of Extramedullary Disease and Prognostic Value in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia Treated with CAR-T Cells." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 3 (2026): 1691. https://doi.org/10.1007/s00259-025-07562-y.

MLA (9th ed.) Citation

X, Yao, et al. "Baseline [18F]FDG PET/CT Characterization of Extramedullary Disease and Prognostic Value in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia Treated with CAR-T Cells." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 3, 2026, p. 1691, https://doi.org/10.1007/s00259-025-07562-y.